Benzinga | Feb 12, 2021 05:59AM EST

Travere Therapeutics Priced 6,55M Share Public Offering of Common Stock @$26.75/Share

Travere Therapeutics, Inc. (NASDAQ:TVTX) y announced the pricing of an underwritten public offering of 6,550,000 shares of its common stock at a price to the public of $26.75 per share. All of the shares are being sold by Travere. The gross proceeds from the offering are expected to be approximately $175.2 million, before deducting the underwriting discounts and commissions and offering expenses. The offering is expected to close on February 17, 2021, subject to customary closing conditions. In addition, Travere has granted the underwriters for the offering a 30-day option to purchase up to an additional 982,500 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

BofA Securities, Jefferies and SVB Leerink are acting as the joint book-running managers for the offering. Canaccord Genuity is acting as lead manager.